Researchers from across the world are gathering in Washington DC for the Alzheimer’s Association International Conference 2015. Today saw announcements from clinical trials with potential new Alzheimer’s treatments.
Author Archives: Robin Brisbourne
Two treatments show promise for symptoms of Alzheimer’s disease
Clinical trial results for two potential symptomatic Alzheimer’s treatments suggest that the drugs may be able to improve memory and thinking, or symptoms of agitation and aggression.
New findings link lifestyle to memory problems
Researchers in the US have announced new findings which highlight factors that could affect the risk of memory problems as we age.
Researchers uncover mechanism linking brain injury to neurodegeneration
Researchers in the US have revealed a mechanism by which traumatic brain injury in mice could damage nerve cells and lead to neurodegeneration.
Brain inflammation targeted in first drug discovery project from £3m Dementia Consortium
Funding worth nearly half a million pounds will unite academics at the University of Southampton with drug discovery experts at the medical research charity MRC Technology, to target the immune system in the hunt for new treatments for Alzheimer’s disease.
Blood protein discovered that can predict 10-year cognitive decline
Researchers based at King’s College London have joined forces with other scientists across the world to discover a protein in blood that appears to predict 10-year decline in memory and thinking skills in healthy people.
Cambridge trial to explore effects of hormone on frontotemporal dementia
Researchers in Cambridge are embarking on a pilot trial to investigate the potential of the hormone oxytocin to combat early symptoms of frontotemporal dementia (FTD), backed by a grant from Alzheimer’s Research UK.
Brain iron levels may help predict how memory and thinking problems will progress
Researchers in Australia have reported that levels of an iron storage protein called ferritin may be useful in predicting how problems with memory and thinking will progress in older people.
Trial shows Mediterranean diet with olive oil or nuts may help cognition
Results of a four-year trial have suggested that a Mediterranean diet, supplemented with either olive oil or nuts, may help thinking skills in some older people. The study is published on Monday 11 May in the journal JAMA Internal Medicine
Trial begins to investigate diabetes drug’s potential for Alzheimer’s disease
It has been reported today that a drug commonly used to treat type 2 diabetes is to be tested in a clinical trial for Alzheimer’s disease. The drug, liraglutide, is to be evaluated in a phase 2 trial of people in the early stages of Alzheimer’s at centres across the UK